-inc-logo-1200x675.png){kind=logo}
Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF – Get Free Report)’s share price traded down 0.7% during mid-day trading on Friday . The company traded as low as $6.53 and last traded at $6.65. 680,630 shares were traded during trading, a decline of 80% from the average session volume of 3,376,665 shares. The stock had previously closed at $6.70.
Mind Medicine (MindMed) Trading Up 1.1 %
The business’s 50-day moving average is $7.29 and its 200-day moving average is $6.94.
Mind Medicine (MindMed) Company Profile
Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.
Further Reading
- Five stocks we like better than Mind Medicine (MindMed)
- How to buy stock: A step-by-step guide for beginners
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- 3 ETFs to Ride the VIX Surge During Market Volatility
- What Are Some of the Best Large-Cap Stocks to Buy?
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.
